SCHEMBL7596775

SCHEMBL7596775

Cc1cc(N(c2ccc(-c3ccccc3)cc2)c2ccc(-c3ccc(-c4cccc5ccccc45)cc3)cc2)ccc1-c1ccc(-c2cccc3ccccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.46
CA1 P00915 5/20 0.46
CA2 P00918 5/20 0.46
CA9 Q16790 5/20 0.46
MCL1 Q07820 1/20 0.42
ACMSD Q8TDX5 1/20 0.42
ENPP3 O14638 1/20 0.42
ENPP1 P22413 1/20 0.42
ESR2 Q92731 1/20 0.41
PPARG P37231 7/20 0.40
PPARA Q07869 7/20 0.40
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
PPARD Q03181 1/20 0.39
TNF P01375 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA7 P36544 1/20 0.38
CRHR1 P34998 1/20 0.38
HDAC8 Q9BY41 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7591957 0.96 CA12 (0.51) CA12CA1CA2CA9MCL1
SCHEMBL7596626 0.96 CA12 (0.51) CA12CA1CA2CA9MCL1
SCHEMBL19292151 0.89 CA12 (0.39) CA12CA1CA2CA9ESR2
SCHEMBL25608179 0.88 CA12 (0.50) CA12CA1CA2CA9MCL1
SCHEMBL17734637 0.88 CA12 (0.45) CA12CA1CA2CA9MCL1
SCHEMBL22432002 0.88 ALOX5 (0.44) CA12CA1CA2CA9MCL1
SCHEMBL25240443 0.87 CA12 (0.47) CA12CA1CA2CA9MCL1
SCHEMBL21869769 0.87 CA12 (0.47) CA12CA1CA2CA9MCL1
SCHEMBL17917947 0.87 CA12 (0.47) CA12CA1CA2CA9MCL1
SCHEMBL21141058 0.87 CA12 (0.47) CA12CA1CA2CA9MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301178-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-09-21 US disclosed
US-20230301178-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-09-21 US disclosed
US-11678568-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2023-06-13 US disclosed
US-11678568-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2023-06-13 US disclosed
US-20210036226-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2021-02-04 US disclosed
US-10804471-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-10-13 US disclosed
US-20170117470-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-04-27 US disclosed
US-20170117470-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-04-27 US disclosed
US-9540315-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-01-10 US disclosed
US-9540315-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-01-10 US disclosed
US-20150141697-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-05-21 US disclosed
US-8940416-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-01-27 US disclosed
US-8940416-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-01-27 US disclosed
US-20120223298-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-09-06 US disclosed
US-20120223298-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-09-06 US disclosed
US-8182933-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-22 US disclosed
US-8182933-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-22 US disclosed
US-20090284140-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-11-19 US disclosed
US-20090284140-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-11-19 US disclosed
WO-2009139358-A1 TRIARYLAMINE DERIVATIVE, LIGHT-EMITTING SUBSTANCE, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-11-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150141697-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885
US-20230301178-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885
US-20210036226-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885
US-20090284140-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885
US-20120223298-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885
US-11678568-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885
US-20170117470-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885
US-10804471-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.